SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Watson Pharmaceuticals, Inc. Third Quarter 2012 Non-GAAP Diluted EPS Increases 24% to $1.35; Net Revenue Increases 19% to $1.29 Billion